Characterization and optimization of a red-shifted fluorescence polarization ADP detection assay. - Wikidata - wikimedia - TriplyDB

Characterization and optimization of a red-shifted fluorescence polarization ADP detection assay.

Characterization and optimization of a red-shifted fluorescence polarization ADP detection assay.

http://www.wikidata.org/entity/Q33404831

about

Method for Assaying the Lipid Kinase Phosphatidylinositol-5-phosphate 4-kinase α in Quantitative High-Throughput Screening (qHTS) Bioluminescent Format Phosphatase-coupled universal kinase assay and kinetics for first-order-rate coupling reaction Two Galpha(i1) rate-modifying mutations act in concert to allow receptor-independent, steady-state measurements of RGS protein activity Comparison of bioluminescent kinase assays using substrate depletion and product formation.A fluorescent, reagentless biosensor for ADP based on tetramethylrhodamine-labeled ParM.Development and validation of a generic fluorescent methyltransferase activity assay based on the transcreener AMP/GMP assay.Regulators of G-protein signaling and their Gα substrates: promises and challenges in their use as drug discovery targets.Analysis of protein-ligand interactions by fluorescence polarization Fluorescence polarization immunoassays for monitoring nucleoside triphosphate diphosphohydrolase (NTPDase) activity.Fluorescence polarization assays in small molecule screening.Bioluminescence Methods for Assaying Kinases in Quantitative High-Throughput Screening (qHTS) Format Applied to Yes1 Tyrosine Kinase, Glucokinase, and PI5P4Kα Lipid Kinase.High-throughput screening for RecA inhibitors using a transcreener adenosine 5'-O-diphosphate assay.A biosensor for fluorescent determination of ADP with high time resolution Development of a Sensitive Assay for SERCA Activity Using FRET Detection of ADP.In Vitro Biochemical Assays for O-GlcNAc-Processing Enzymes.Development and validation of a transcreener assay for detection of AMP- and GMP-producing enzymes.

P2860

Q28551871-1FB2DE26-3B22-4ECE-877A-A33425F3803D Q28741504-A7940993-907A-4DE7-8F1B-F6EA885CEE40 Q33509780-C4927ADB-DDC5-4381-B4CA-FDC24A633AB3 Q33522759-2B047B9C-3CBB-4888-976A-CE43FA095EC6 Q33793413-2FF25F80-A4C2-4F3F-B07F-042D203AD2D2 Q34034286-29A4857B-EDAA-4B41-8C4C-BD6911DF8ECB Q34198530-FE8FE0E3-6B86-40C5-9AD7-523B5528C953 Q35177806-B91C31E2-D748-4AEE-BA8E-9468728BC7FD Q35394974-8CF3BFAE-6110-459D-B8EB-09371526F39A Q35750597-31A50E4E-85D1-4533-A292-88862707BD42 Q35821339-80F417AE-54BF-48E9-AD8E-C9A8EAADD515 Q36029187-7718AD68-771E-4781-8371-190E2D36EA74 Q37446066-3EAB2CBD-B5E6-486E-A72A-D0E59F6CD9D4 Q37696282-A230AEE4-9C81-48EE-9DB4-E0D48D46F35A Q39285550-C3084141-DCB8-4343-80A6-12772B27FF21 Q41581326-ADC00C5F-0551-450A-A741-3FC310C973E6

P2860

Characterization and optimization of a red-shifted fluorescence polarization ADP detection assay.

http://www.wikidata.org/entity/Q33404831

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Characterization and optimizat ...... arization ADP detection assay.

@ast

Characterization and optimizat ...... arization ADP detection assay.

@en

type

label

Characterization and optimizat ...... arization ADP detection assay.

@ast

Characterization and optimizat ...... arization ADP detection assay.

@en

prefLabel

Characterization and optimizat ...... arization ADP detection assay.

@ast

Characterization and optimizat ...... arization ADP detection assay.

@en

P1433

Q33404831-1293E428-9766-4DA4-ADD7-8439A459C793

P1476

Q33404831-1849791F-AB8E-4A15-B9FE-5135ABC662FF

P2093

Q33404831-057A2C44-17D6-48FB-9D74-E31E2EFF832D

Q33404831-0BFA8AFD-04AE-4052-8371-7995894E6245

Q33404831-1B03BE9F-9078-4797-A187-C0A31ADBC47E

Q33404831-476AB62A-17B6-46D0-8E9C-BEE5F9CA5084

Q33404831-56F5B7D6-15D5-4D15-AA82-46E6F5CF472D

Q33404831-76F6D9B3-75A9-4380-B019-5627A83F484A

Q33404831-7AD81D15-B215-40CD-8FE2-4B0CC85BAF8B

Q33404831-8C60D883-F589-446D-AE81-8A39588A2D27

Q33404831-8CD4F83C-9AD3-4C19-A5A0-2DE2A509F937

Q33404831-AB1A82BD-7CE0-4138-ACDF-15D7361E8D34

P2860

Q33404831-0B3EEC05-5F93-44B8-91D2-A004B1FF9C39

Q33404831-1115E17B-BB44-4940-B7CF-659BCB3DC955

Q33404831-1D340D26-2732-4533-98BF-8612D7DC179F

Q33404831-2A69B166-2C96-4580-BDF4-A000FB66DA33

Q33404831-2CC36602-45AF-4400-B70D-17EC2168B22D

Q33404831-49922DB2-2E45-4716-B003-1A7A66213E6F

Q33404831-4B5ED2E3-2601-4A76-A78C-A86F79ECE85D

Q33404831-50F6F42A-8111-474F-9C63-D8D16AF29773

Q33404831-5421C9C3-0679-4FC5-8C78-5B5154E27DD6

Q33404831-583DE6CC-63FA-4952-8553-2CCDD1C24566

P304

Q33404831-8BD22B13-BDAC-49BD-B5A5-A12B1693B517

P31

Q33404831-0D188796-7DF6-4462-831D-ABCB45AC1902

P356

Q33404831-1D9C96AD-DD1F-479F-9EBE-486CC796C5D6

P433

Q33404831-A6A8333A-A953-47C5-A9EC-35B9175293B2

P478

Q33404831-E442880F-0EAA-4AF5-B5AA-D3B999A555EE

P577

Q33404831-E539B640-E0ED-4E14-A060-8A74A463BC20

P5875

Q33404831-9D609C7D-F0A5-4486-B52C-F7545F5FEE7E

P698

Q33404831-A8232F86-3B6E-40C0-9015-BAAC63779C91

P932

Q33404831-D78169A1-4F9E-4D70-A2D4-63244F29A805

P356

P1433

Assay and Drug Development Technologies

P1476

Characterization and optimizat ...... arization ADP detection assay.

@en

P2093

Andrew L Kopp

http://www.w3.org/2001/XMLSchema#string

Brad R Larson

http://www.w3.org/2001/XMLSchema#string

Cori A Pinchard

http://www.w3.org/2001/XMLSchema#string

Guido J R Zaman

http://www.w3.org/2001/XMLSchema#string

Jorrit J Hornberg

http://www.w3.org/2001/XMLSchema#string

Karen M Kleman-Leyer

http://www.w3.org/2001/XMLSchema#string

Mark D Koeff

http://www.w3.org/2001/XMLSchema#string

Robert G Lowery

http://www.w3.org/2001/XMLSchema#string

Sebastianus A T van de Kar

http://www.w3.org/2001/XMLSchema#string

Thane A Westermeyer

http://www.w3.org/2001/XMLSchema#string

P2860

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

A synthetic inhibitor of the mitogen-activated protein kinase cascade

Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals

Protein kinases--the major drug targets of the twenty-first century?

Multiplexed enzyme assays in capillary electrophoretic single-use microfluidic devices.

Overcoming compound interference in fluorescence polarization-based kinase assays using far-red tracers.

Development of a Transcreener kinase assay for protein kinase A and demonstration of concordance of data with a filter-binding assay format.

A generic time-resolved fluorescence assay for serine/threonine kinase activity: application to Cdc7/Dbf4.

Fluorescence spectroscopic profiling of compound libraries.

Protein kinases as therapeutic targets.

P304

56-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/ADT.2008.175

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23971148

http://www.w3.org/2001/XMLSchema#string

P698

19187009

http://www.w3.org/2001/XMLSchema#string

P932

2956686

http://www.w3.org/2001/XMLSchema#string